The selection of reference preparations is an important task in the evaluation of consistency. Both the development of generic drugs and the quality evaluation of generic drugs are based on an in-depth interpretation of the reference preparations. However, the New Deal only clarified part of the list of reference preparations, and delineated the selection range of reference preparations. This requires relevant companies to take the initiative to select the appropriate reference preparation, clarify the reference preparation information, and prepare to complete the consistency evaluation.